Immune-related adverse events (irAEs) predict therapeutic efficacy of an anti-PD-1 antibody in cancer patients
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-10, Vol.29, p.viii435-viii435 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | viii435 |
|---|---|
| container_issue | |
| container_start_page | viii435 |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Rogado, J. Romero Laorden, N. Sanchez Torres, J.M. Ballesteros Garcia, A.I. Pacheco-Barcia, V.E. Arranz, R. Mondéjar Solís, R. Gullón, P. Lorenzo, A. Colomer Bosch, R. |
| description | |
| doi_str_mv | 10.1093/annonc/mdy288.098 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy288_098</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419496828</els_id><sourcerecordid>S0923753419496828</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2308-d363dc724b8acd565d206a5f196ba9262ca9a37c53c971ab8a30211d42a5bfd83</originalsourceid><addsrcrecordid>eNp9kM1Lw0AQxRdRbK3-AV5kj3pI3Y_mY_FUtH6AoAc9h8nsBFeaTdhNC_3vTY16FAZmDu895v0YO5diLoXR1-B96_G6sTtVFHNhigM2lWlmkkIs5CGbCqN0kqd6MWEnMX4KITKjzDGbaCV1LkU2Zf6paTaekkBr6MlysFsKkThtyfeRX7qwXMUr3gWyDnvef1CAjja9Q0517RBwx9uagx-md8nrXSK_r6q1O-48R_BIgXfQu33gKTuqYR3p7GfP2Pv96u32MXl-eXi6XT4nqLQoEqszbTFXi6oAtGmWWiUySGtpsgqMyhSCAZ1jqtHkEgaVFkpKu1CQVrUt9IzJMRdDG2OguuyCayDsSinKPbtyZFeO7MqB3eC5GD3dpmrI_jl-YQ2Cm1FAw-dbR6GMOLTCAU0g7Evbun_ivwB97oKl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Immune-related adverse events (irAEs) predict therapeutic efficacy of an anti-PD-1 antibody in cancer patients</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Rogado, J. ; Romero Laorden, N. ; Sanchez Torres, J.M. ; Ballesteros Garcia, A.I. ; Pacheco-Barcia, V.E. ; Arranz, R. ; Mondéjar Solís, R. ; Gullón, P. ; Lorenzo, A. ; Colomer Bosch, R.</creator><creatorcontrib>Rogado, J. ; Romero Laorden, N. ; Sanchez Torres, J.M. ; Ballesteros Garcia, A.I. ; Pacheco-Barcia, V.E. ; Arranz, R. ; Mondéjar Solís, R. ; Gullón, P. ; Lorenzo, A. ; Colomer Bosch, R.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy288.098</identifier><identifier>PMID: 32137106</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-10, Vol.29, p.viii435-viii435</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32137106$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rogado, J.</creatorcontrib><creatorcontrib>Romero Laorden, N.</creatorcontrib><creatorcontrib>Sanchez Torres, J.M.</creatorcontrib><creatorcontrib>Ballesteros Garcia, A.I.</creatorcontrib><creatorcontrib>Pacheco-Barcia, V.E.</creatorcontrib><creatorcontrib>Arranz, R.</creatorcontrib><creatorcontrib>Mondéjar Solís, R.</creatorcontrib><creatorcontrib>Gullón, P.</creatorcontrib><creatorcontrib>Lorenzo, A.</creatorcontrib><creatorcontrib>Colomer Bosch, R.</creatorcontrib><title>Immune-related adverse events (irAEs) predict therapeutic efficacy of an anti-PD-1 antibody in cancer patients</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kM1Lw0AQxRdRbK3-AV5kj3pI3Y_mY_FUtH6AoAc9h8nsBFeaTdhNC_3vTY16FAZmDu895v0YO5diLoXR1-B96_G6sTtVFHNhigM2lWlmkkIs5CGbCqN0kqd6MWEnMX4KITKjzDGbaCV1LkU2Zf6paTaekkBr6MlysFsKkThtyfeRX7qwXMUr3gWyDnvef1CAjja9Q0517RBwx9uagx-md8nrXSK_r6q1O-48R_BIgXfQu33gKTuqYR3p7GfP2Pv96u32MXl-eXi6XT4nqLQoEqszbTFXi6oAtGmWWiUySGtpsgqMyhSCAZ1jqtHkEgaVFkpKu1CQVrUt9IzJMRdDG2OguuyCayDsSinKPbtyZFeO7MqB3eC5GD3dpmrI_jl-YQ2Cm1FAw-dbR6GMOLTCAU0g7Evbun_ivwB97oKl</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Rogado, J.</creator><creator>Romero Laorden, N.</creator><creator>Sanchez Torres, J.M.</creator><creator>Ballesteros Garcia, A.I.</creator><creator>Pacheco-Barcia, V.E.</creator><creator>Arranz, R.</creator><creator>Mondéjar Solís, R.</creator><creator>Gullón, P.</creator><creator>Lorenzo, A.</creator><creator>Colomer Bosch, R.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>Immune-related adverse events (irAEs) predict therapeutic efficacy of an anti-PD-1 antibody in cancer patients</title><author>Rogado, J. ; Romero Laorden, N. ; Sanchez Torres, J.M. ; Ballesteros Garcia, A.I. ; Pacheco-Barcia, V.E. ; Arranz, R. ; Mondéjar Solís, R. ; Gullón, P. ; Lorenzo, A. ; Colomer Bosch, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2308-d363dc724b8acd565d206a5f196ba9262ca9a37c53c971ab8a30211d42a5bfd83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rogado, J.</creatorcontrib><creatorcontrib>Romero Laorden, N.</creatorcontrib><creatorcontrib>Sanchez Torres, J.M.</creatorcontrib><creatorcontrib>Ballesteros Garcia, A.I.</creatorcontrib><creatorcontrib>Pacheco-Barcia, V.E.</creatorcontrib><creatorcontrib>Arranz, R.</creatorcontrib><creatorcontrib>Mondéjar Solís, R.</creatorcontrib><creatorcontrib>Gullón, P.</creatorcontrib><creatorcontrib>Lorenzo, A.</creatorcontrib><creatorcontrib>Colomer Bosch, R.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rogado, J.</au><au>Romero Laorden, N.</au><au>Sanchez Torres, J.M.</au><au>Ballesteros Garcia, A.I.</au><au>Pacheco-Barcia, V.E.</au><au>Arranz, R.</au><au>Mondéjar Solís, R.</au><au>Gullón, P.</au><au>Lorenzo, A.</au><au>Colomer Bosch, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune-related adverse events (irAEs) predict therapeutic efficacy of an anti-PD-1 antibody in cancer patients</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29</volume><spage>viii435</spage><epage>viii435</epage><pages>viii435-viii435</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32137106</pmid><doi>10.1093/annonc/mdy288.098</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-10, Vol.29, p.viii435-viii435 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdy288_098 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Immune-related adverse events (irAEs) predict therapeutic efficacy of an anti-PD-1 antibody in cancer patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A36%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune-related%20adverse%20events%20(irAEs)%20predict%20therapeutic%20efficacy%20of%20an%20anti-PD-1%20antibody%20in%20cancer%20patients&rft.jtitle=Annals%20of%20oncology&rft.au=Rogado,%20J.&rft.date=2018-10&rft.volume=29&rft.spage=viii435&rft.epage=viii435&rft.pages=viii435-viii435&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy288.098&rft_dat=%3Celsevier_cross%3ES0923753419496828%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32137106&rft_els_id=S0923753419496828&rfr_iscdi=true |